Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect.Single-dose vials of Zepbound purchased through the Zepbound Self Pay Journey Program on LillyDirect will now cost $299 per month – down from $349 – for patients with a valid prescription.The 5-milligram dose will also be priced at $399 per month, down from $499. All other approved doses will cost $449 per month, Eli Lilly said.LillyDirect, which launched in early 2024, allows some consumers who...

1 week ago

On HALO